Suanfarma Suanfarma

X

CAS 116169-90-5 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 116169-90-5
Also known as: 116169-90-5, N2-(1s-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoroacetyl-l-lysine, N2-(s)-1-ethoxycarbonyl-3-phenylpropyl-n8-trifluoroacetyl-l-lysine, (2s)-2-[[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-[(2,2,2-trifluoroacetyl)amino]hexanoic acid, N2-[(1s)-ethoxycarbonyl-3-phenylpropyl]-n6-trifluoroacetyl-l-lysine, N2-(1-(s)-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoroacetyl-l-lysine
Molecular Formula
C20H27F3N2O5
Molecular Weight
432.4  g/mol
InChI Key
YNLDFNVDZZGPHE-HOTGVXAUSA-N

1 2D Structure

CAS 116169-90-5

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-[(2,2,2-trifluoroacetyl)amino]hexanoic acid
2.1.2 InChI
InChI=1S/C20H27F3N2O5/c1-2-30-18(28)16(12-11-14-8-4-3-5-9-14)25-15(17(26)27)10-6-7-13-24-19(29)20(21,22)23/h3-5,8-9,15-16,25H,2,6-7,10-13H2,1H3,(H,24,29)(H,26,27)/t15-,16-/m0/s1
2.1.3 InChI Key
YNLDFNVDZZGPHE-HOTGVXAUSA-N
2.1.4 Canonical SMILES
CCOC(=O)C(CCC1=CC=CC=C1)NC(CCCCNC(=O)C(F)(F)F)C(=O)O
2.1.5 Isomeric SMILES
CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](CCCCNC(=O)C(F)(F)F)C(=O)O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 116169-90-5

2. N2-(1s-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoroacetyl-l-lysine

3. N2-(s)-1-ethoxycarbonyl-3-phenylpropyl-n8-trifluoroacetyl-l-lysine

4. (2s)-2-[[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-[(2,2,2-trifluoroacetyl)amino]hexanoic Acid

5. N2-[(1s)-ethoxycarbonyl-3-phenylpropyl]-n6-trifluoroacetyl-l-lysine

6. N2-(1-(s)-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoroacetyl-l-lysine

7. N2-[(1s)-ethoxycarbony1-3-phenylpropyl]-n6-trifluoroacetyl-l-lysine

8. N2-[1-(s)-ethoxycarbonyl-3-phenylpropyl]-n6-trifluoroacetyl-l-lysine

9. Lisinopril Impurity 18

10. Schembl901542

11. Dtxsid50437842

12. Mfcd06658211

13. Zinc21992208

14. Akos015888707

15. Ac-6229

16. As-15712

17. Cs-0186155

18. E77203

19. 169e905

20. A803567

21. J-005805

22. N2-[(s)-1-ethoxycarbonyl-3-phenylpropyl]-n6-trifluoroacetyl-l-lysine

23. N~2~-[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-n~6~-(trifluoroacetyl)-l-lysine

24. (2s)-2-[[(1s)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-6-[(2,2,2-trifluoroacetyl)amino]hexanoic Acid;n2-(1s-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoroacetyl-l-lysine

25. (2s)-2-{[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-6-(trifluoroacetamido)hexanoic Acid

26. (s)-2-(((s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-6-(2,2,2-trifluoroacetamido)hexanoicacid

27. (s)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)-6-(2,2,2-trifluoroacetamido)hexanoic Acid

28. Benzenebutanoic Acid, Alpha-[[(1s)-1-carboxy-5-[(2,2,2-trifluoroacetyl)amino]pentyl]amino]-, 1-ethyl Ester, (alphas)-

2.3 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 432.4 g/mol
Molecular Formula C20H27F3N2O5
XLogP31.3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count14
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area105
Heavy Atom Count30
Formal Charge0
Complexity551
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
103300-91-0
Lisinopril
Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer & exporter of Bulk drugs / Se...
Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer & exporter of Bulk drugs / Semi finish formulations & Intermediate and also has a GMP certified Manufacturing facility for Phytochemicals / Herbal extract and Enzymes through our associates.
Zeon Pharma Industries India Pvt Ltd Company Banner

India Med Expo

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
URL Supplier Web Content
16652-71-4
Lisinopril
Established in the early 90’s SCL offers a wide range of Active Pharmaceutical Ingredients and Intermed...
Established in the early 90’s SCL offers a wide range of Active Pharmaceutical Ingredients and Intermediates to its customers worldwide. SCL’s products are exported to Europe, Japan, Russia, South and Central America, ASEAN, W. Asia, MENA regions. SCL’s manufacturing facilities have been built to comply with EU GMP and U.S. FDA norms, and the API facility has been successfully certified as EU GMP compliant five times by the European Authorities. Latest certification was carried out by German Health Authority.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
103300-91-0
Lisinopril
Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY